3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
9
Observational
1
Sponsor
Cancer Type
Breast
7
Gastrointestinal
6
Genitourinary
5
Plasma cell
4
Thoracic
2
Other hematologic neoplasm
2
Lymphoid
2
Dermatologic
2
Tumor-Agnostic
1
Sarcoma
1
Myeloid
1
Head & Neck
1
Gynecologic
1
CNS
1
Conditions
Locally Advanced or Metastatic Infantile Fibrosarcoma Harboring an NTRK Gene Fusion
1
Interventions
Blood Specimen Collection
14
Surveys and Questionnaires
13
Surgical Procedures, Operative
12
Gene Expression Profiling
10
Observation
7
Amplified Fragment Length Polymorphism Analysis
7
Polymerase Chain Reaction
6
Drug Therapy
6
Radiotherapy
5
Microarray Analysis
5
Immunohistochemistry
5
Psychiatric Rehabilitation
4
Imatinib Mesylate
4
Base Sequence
4
regorafenib
3
Trabectedin
3
Tissue Banks
3
Therapeutics
3
Sunitinib
3
Specimen Handling
3
Reverse Transcriptase Polymerase Chain Reaction
3
Radiation
3
Methods
3
Magnetic Resonance Imaging
3
Interviews as Topic
3
Doxorubicin
3
Biopsy
3
ripretinib
2
mifamurtide
2
Watchful Waiting
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Standard of Care
×
Sarcoma
×
Clear all
NCT05236257
2024-12-10
EPI VITRAKVI
Bayer
Completed
93 enrolled
14 charts